Erectile Dysfunction Drug Shows Mixed Results in Alzheimer's | HappeningNow.news

Health · 8 views

Erectile Dysfunction Drug Shows Mixed Results in Alzheimer's

Source Summary Published 5h 06m ago Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 8 Community interest
Brief read Under 1 min brief 34 words

Summary

(MedPage Today) -- Mirodenafil (known as AR1001), an oral phosphodiesterase-5 inhibitor approved in South Korea to treat erectile dysfunction, showed mixed results in people with early Alzheimer's disease in the phase III POLARIS-AD trial.

Read original at MedPage Today

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page